- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
004310
KSC
Week ended 07 Aug 2026
Weekly Investor Report
Hyundai Pharmaceutical Co., Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
6,150 KRW
14.7%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -29.2% below the Trend Line and sits at 21.4% of its 52-week range. The latest completed week returned 14.7%, after a 25.9% four-week move. The latest news-sentiment score is 50/100.
Setup score
38
out of 100
Latest Close
6,150 KRW
7 Aug 2026
1W Return
14.7%
latest completed week
4W Return
25.9%
short-term follow-through
12W Return
-18.4%
quarterly tape
Trend Breadth
71.2%
37 of 52 weeks active
Volume Ratio
1.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 38.90% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
14.7%
Latest completed week; four-week move 25.9%.
Indicator stack
39/50
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.90%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -29.2% below the Trend Line and sits at 21.4% of its 52-week range. The latest completed week returned 14.7%, after a 25.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0712-week average 0.17
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 25.9% over four weeks, -18.4% over 12 weeks, and 60.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year37
Trend breadth71.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.27Latest activity-pressure read.
Pressure change65.5%Four-week change in activity pressure.
Leadership-26.68Latest relative-leadership reading.
RS change48.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-61.4%Distance below the 52-week high.
13-week volatility23.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher7 of 2619 weeks finished lower.
Best week+55.6%Week of 17 Jul.
Worst week-25.8%Week of 26 Jun.
Latest week+14.7%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains3
Flat weeks0
Modest losses5
Sharp losses14
Recent vol23.0%13-week weekly-return volatility.
Base vol17.3%52-week weekly-return volatility.
Up/down split20/32Count of positive and negative weeks in the 52-week window.
Average skew16.1% / -6.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorKR Healthcare
4-week rank2 / 63
Group average4.4%
Trend breadth1.6%
Trend1.6%active weekly trend signals
MD9.5%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
IndustryKR Drug Manufacturers - Specialty & Generic
4-week rank1 / 44
Group average4.1%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD4.5%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape30/100
Trend, activity pressure, participation, and risk combine to a 30/100 tape read.
Indicator analysis10/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.07; No reversal markers Next-Week ExpectancyNegative 38.90%Next-week expectancy is negative with a 38.90% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Enterprise value to EBITDA forward of Hyundai Pharmaceutical Co., Ltd. – KRX:004310 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 6,150 KRW | 14.7% | 8,684 KRW | 4,856 KRW | -0.27 | -26.68 | 14.3M | Off |
| 31 Jul 2026 | 5,360 KRW | -12.3% | 8,749 KRW | 4,843 KRW | -0.47 | -39.54 | 11.0M | Off |
| 24 Jul 2026 | 6,110 KRW | -19.6% | 8,871 KRW | 4,836 KRW | -0.58 | -32.42 | 36.4M | Off |
| 17 Jul 2026 | 7,600 KRW | 55.6% | 8,956 KRW | 4,823 KRW | -0.77 | -17.92 | 42.2M | Off |
| 10 Jul 2026 | 4,885 KRW | -5.3% | 8,902 KRW | 4,800 KRW | -0.80 | -52.01 | 2.2M | Off |
| 3 Jul 2026 | 5,160 KRW | -14.7% | 8,942 KRW | 4,793 KRW | -0.90 | -53.44 | 449.6K | Off |
| 26 Jun 2026 | 6,050 KRW | -25.8% | 8,938 KRW | 4,784 KRW | -0.97 | -47.88 | 1.6M | Off |
| 19 Jun 2026 | 8,150 KRW | 42.2% | 8,860 KRW | 4,771 KRW | -1.00 | -35.12 | 14.9M | Off |
| 12 Jun 2026 | 5,730 KRW | -3.5% | 8,708 KRW | 4,746 KRW | -1.28 | -49.35 | 262.1K | Off |
| 5 Jun 2026 | 5,940 KRW | -11.9% | 8,642 KRW | 4,735 KRW | -1.18 | -48.09 | 298.8K | Off |
| 29 May 2026 | 6,740 KRW | -12.0% | 8,564 KRW | 4,727 KRW | -1.08 | -43.68 | 1.4M | Off |
| 22 May 2026 | 7,660 KRW | 1.6% | 8,462 KRW | 4,714 KRW | -1.00 | -31.33 | 1.4M | Off |
| 15 May 2026 | 7,540 KRW | -5.8% | 8,332 KRW | 4,695 KRW | -0.99 | -29.57 | 2.4M | Off |
| 8 May 2026 | 8,000 KRW | -7.2% | 8,206 KRW | 4,677 KRW | -0.95 | -25.59 | 2.7M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.